Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 7 | 2022 | 5694 | 0.480 |
Why?
|
| Audiovisual Aids | 1 | 2012 | 99 | 0.380 |
Why?
|
| Mutagenesis | 2 | 2012 | 1227 | 0.320 |
Why?
|
| Ultraviolet Rays | 2 | 2012 | 1079 | 0.300 |
Why?
|
| Molecular Conformation | 1 | 2009 | 543 | 0.290 |
Why?
|
| Databases, Protein | 1 | 2008 | 386 | 0.260 |
Why?
|
| Skin Neoplasms | 3 | 2022 | 5809 | 0.260 |
Why?
|
| Melanocytes | 3 | 2022 | 509 | 0.250 |
Why?
|
| Computer Graphics | 1 | 2007 | 338 | 0.250 |
Why?
|
| Protein Conformation | 2 | 2011 | 3936 | 0.230 |
Why?
|
| Publishing | 1 | 2009 | 832 | 0.190 |
Why?
|
| Oxygen | 1 | 2012 | 4226 | 0.180 |
Why?
|
| Mutation | 12 | 2022 | 30006 | 0.170 |
Why?
|
| Biochemistry | 2 | 2012 | 114 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2013 | 2054 | 0.160 |
Why?
|
| Models, Molecular | 4 | 2012 | 5413 | 0.150 |
Why?
|
| Software | 2 | 2008 | 4433 | 0.140 |
Why?
|
| Sequence Alignment | 2 | 2012 | 2175 | 0.140 |
Why?
|
| Endometrial Neoplasms | 2 | 2016 | 1365 | 0.130 |
Why?
|
| Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2016 | 287 | 0.120 |
Why?
|
| Pelvic Neoplasms | 1 | 2016 | 247 | 0.120 |
Why?
|
| Uveal Neoplasms | 1 | 2017 | 341 | 0.110 |
Why?
|
| Genome-Wide Association Study | 2 | 2012 | 12670 | 0.110 |
Why?
|
| Genome, Human | 3 | 2017 | 4423 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 5775 | 0.100 |
Why?
|
| Ribosomal Proteins | 1 | 2014 | 370 | 0.100 |
Why?
|
| Encyclopedias as Topic | 1 | 2011 | 19 | 0.090 |
Why?
|
| Visual Cortex | 1 | 2019 | 1105 | 0.090 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 242 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 370 | 0.090 |
Why?
|
| Evolution, Molecular | 2 | 2016 | 1882 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 717 | 0.090 |
Why?
|
| Oncogenes | 2 | 2013 | 1220 | 0.090 |
Why?
|
| Genetic Code | 1 | 2010 | 138 | 0.090 |
Why?
|
| Sunlight | 1 | 2012 | 337 | 0.090 |
Why?
|
| Online Systems | 1 | 2011 | 182 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 518 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 3634 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 2091 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13404 | 0.080 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 734 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3869 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5300 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 569 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2452 | 0.070 |
Why?
|
| Telomerase | 1 | 2013 | 741 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2012 | 4060 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2014 | 1977 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2014 | 782 | 0.070 |
Why?
|
| Open Reading Frames | 1 | 2010 | 811 | 0.070 |
Why?
|
| Proteins | 3 | 2011 | 5993 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 6340 | 0.060 |
Why?
|
| Polyesters | 1 | 2008 | 371 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2057 | 0.060 |
Why?
|
| Teaching | 1 | 2012 | 1169 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2014 | 2667 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9416 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 2413 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 8529 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 13630 | 0.050 |
Why?
|
| Oximes | 2 | 2013 | 303 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 2914 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2014 | 3026 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 2223 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 3779 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 9001 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2013 | 5662 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 17598 | 0.040 |
Why?
|
| Base Sequence | 1 | 2010 | 12404 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2012 | 18926 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4739 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7189 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2008 | 1865 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2017 | 31 | 0.040 |
Why?
|
| Imidazoles | 2 | 2013 | 1173 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9566 | 0.040 |
Why?
|
| Humans | 16 | 2022 | 761098 | 0.040 |
Why?
|
| Internet | 1 | 2008 | 3094 | 0.030 |
Why?
|
| Phylogeny | 2 | 2016 | 2809 | 0.030 |
Why?
|
| Binding Sites | 2 | 2014 | 5993 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6919 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 180 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5318 | 0.030 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2013 | 92 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
| raf Kinases | 1 | 2013 | 118 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11732 | 0.030 |
Why?
|
| Organoids | 1 | 2019 | 744 | 0.030 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2013 | 95 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 27097 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 93 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 782 | 0.030 |
Why?
|
| Indazoles | 1 | 2014 | 304 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 332 | 0.020 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 493 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 314 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 13382 | 0.020 |
Why?
|
| Pyrimidinones | 1 | 2013 | 385 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 636 | 0.020 |
Why?
|
| Information Management | 1 | 2011 | 100 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 958 | 0.020 |
Why?
|
| Sample Size | 1 | 2013 | 841 | 0.020 |
Why?
|
| Information Services | 1 | 2011 | 236 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 1989 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 2010 | 192 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2019 | 3430 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1240 | 0.020 |
Why?
|
| Ethylamines | 1 | 2008 | 17 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20120 | 0.020 |
Why?
|
| Pyridones | 1 | 2013 | 809 | 0.020 |
Why?
|
| Methacrylates | 1 | 2008 | 109 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2011 | 573 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 965 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 896 | 0.020 |
Why?
|
| X-Rays | 1 | 2008 | 308 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 420 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 16947 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 2913 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4849 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 449 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6225 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 1830 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2010 | 1257 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1891 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1162 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2011 | 1395 | 0.010 |
Why?
|
| Artifacts | 1 | 2013 | 1913 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4250 | 0.010 |
Why?
|
| Neoplasms | 1 | 2013 | 22125 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 2864 | 0.010 |
Why?
|
| Cell Count | 1 | 2008 | 1831 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4109 | 0.010 |
Why?
|
| Middle Aged | 5 | 2017 | 220835 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2820 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4908 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2011 | 1126 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9300 | 0.010 |
Why?
|
| DNA Damage | 1 | 2012 | 2443 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1187 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3819 | 0.010 |
Why?
|
| Aged | 4 | 2017 | 169266 | 0.010 |
Why?
|
| Female | 6 | 2017 | 392458 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2008 | 1488 | 0.010 |
Why?
|
| Animals | 4 | 2019 | 168083 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2014 | 23415 | 0.010 |
Why?
|
| RNA | 1 | 2010 | 2708 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7567 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5828 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2293 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58946 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 1684 | 0.010 |
Why?
|
| Male | 5 | 2017 | 360675 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2014 | 6565 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13506 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7574 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 14023 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 3838 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4308 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16572 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12096 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9455 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81324 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59199 | 0.010 |
Why?
|
| Adult | 2 | 2017 | 221083 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 41486 | 0.010 |
Why?
|
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_